Skip to Content

7767 100 (Celebrex 100 mg)

Generic Name: celecoxib

Pill with imprint 7767 100 is White / Blue, Capsule-shape and has been identified as Celebrex 100 mg. It is supplied by Pfizer U.S. Pharmaceuticals Group.

Celebrex is used in the treatment of pain; osteoarthritis; rheumatoid arthritis; ankylosing spondylitis; familial adenomatous polyposis (and more), and belongs to the drug class cox-2 inhibitors. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Celebrex 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 7767 100

Celebrex 100 mg 7767 100
Celebrex 100 mg 7767 100
Celebrex 100 mg 7767 100 Front
Celebrex 100 mg 7767 100 Back
Celebrex 100 mg 7767 100


Generic Name:
7767 100
100 mg
White / Blue
18.00 mm
Prescription only
Drug Class:
Cox-2 inhibitors
Pregnancy Category:
C - Risk cannot be ruled out - prior to 30 weeks gestation
D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Pfizer U.S. Pharmaceuticals Group
Inactive Ingredients:
croscarmellose sodium
lactose monohydrate
magnesium stearate
sodium lauryl sulfate
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
00591-2820 Watson Pharmaceuticals, Inc.
59762-1516 Greenstone LLC
00378-4066 Mylan Pharmaceuticals Inc.
68180-0597 Lupin Pharmaceuticals, Inc.
33261-0653 Aidarex Pharmacuticals, LLC (repackager)
33358-0069 CorePharma, LLC (repackager)
63874-0517 Altura Pharmaceuticals Inc. (repackager)
49999-0383 Lake Erie Medical and Surgical Supply (repackager)
66267-0046 Nucare Pharmaceuticals Inc. (repackager)
66116-0117 Medvantx Inc. (repackager)
54868-4107 Physicians Total Care Inc. (repackager)
55289-0451 PDRX Pharmaceuticals Inc. (repackager)
52959-0540 H.J. Harkins Company, Inc. (repackager)
54569-4671 A-S Medication Solutions, LLC (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.